AI assistant
ChemoMetec Major Shareholding Notification 2021
3356_mrq_2021-11-18_60804060-5543-440a-bd6c-d74853746b80.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
ANNOUNCEMENT NO. 215 18 November 2021
Major shareholder announcement
Pursuant to section 30 of the Capital Markets Act, it is hereby announced that ChemoMetec Holding A/S has informed ChemoMetec A/S that ChemoMetec Holding A/S, after a distribution of a total of 1,616,100 shares holds less than 5% of the share capital and voting rights in ChemoMetec A/S.
After the distribution, ChemoMetec Holding A/S holds a total of 183,900 shares, corresponding to 1.06% of the share capital and voting rights in ChemoMetec A/S.
The distribution of the total of 1,616,100 shares in ChemoMetec A/S has taken place in three equal parts of 538,700 shares to each of the three owner companies of ChemoMetec Holding A/S.
Each of the three owner companies now holds a total of 538,700 shares, corresponding to 3.10% of the share capital and voting rights in ChemoMetec A/S.
For further information, please contact
Steen Søndergaard, CEO, ChemoMetec A/S Tel: (+45) 4813 1020
About ChemoMetec A/S
ChemoMetec develops, manufactures and markets instruments for cell counting and a wide range of other measurements. ChemoMetec's instruments are marketed to the pharmaceutical, biotech and agricultural industries worldwide. ChemoMetec's customers include some of the world's leading pharmaceutical companies, such as Novartis, Novo Nordisk, H. Lundbeck, Merck, AstraZeneca and Johnson & Johnson.
ChemoMetec was founded in 1997 and is listed on the Nasdaq Copenhagen stock exchange. For more information, go to www.chemometec.com.
ChemoMetec A/S Gydevang 43 DK-3450 Allerød Denmark
Phone +45 4813 1020 Fax +45 4813 1021 www.chemometec.com CVR.No. 1982.8131